Key molecular players, such as ATRX, OLIG2, MGMT, and IDH2 proteins, contribute to critical oncogenic processes like chromatin remodelling, glioblastoma cell fate and de-differentiation, DNA repair and metabolic reprogramming. Here, IDH2 is linked to glioblastoma.